CELLCIPHR
Live / Registered — Registered and renewed (as of 24 May 2017)
What this means for you
Registered since 27 Nov 2007. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Nov 2017).
Record
- Serial number
- 77121298
- Registration number
- 3343078
- Mark type
- Stylized text
- Filed
- 02 Mar 2007
- Published for opposition
- 11 Sept 2007
- Registered
- 27 Nov 2007
- Next maintenance due
- 27 Nov 2017
- Attorney of record
- William E OBrien, Esq.
Goods and services
- Class 001 — Chemicals: [Biochemical reagents commonly known as probes, for detecting and analyzing molecules in protein or nucleotide arrays; Biochemicals namely, polypeptides for in vitro research use; Biochemicals, namely, monoclonal antibodies for in vitro scientific or research use; Biological Tissue, namely, a set of matched frozen and fixed human biological specimens derived from the division of one original specimen for use in scientific and medical research; Chemical preparations for scientific purposes; Chemical test kits for cell assays for laboratory or research use; Cytological fixatives; Diagnostic preparations for scientific or research use; Enzymes for scientific and research purposes; Nucleic acid sequences and chemical reagents for other than medical and veterinary purposes; Reagents for scientific or medical research use; Reagents for use in scientific apparatus for chemical or biological analysis; Testing kits containing peptide substrates used in analyzing and detecting certain toxins for laboratory or research use]
- Class 042 — Scientific and technological services: [ Chemical, biochemical, biological and bacteriological research and analysis; Chemistry consultation; Consultancy pertaining to pharmacology; Design for others in the field of cellular profiling and biomedical assays; Development of new technology for others in the field of biomedical research; Diagnostic services in the field of biomedicine; Information on the subject of scientific research in the field of biochemistry and biotechnology; ] Laboratory research in the field of drug discovery and drug development; Measurement evaluations in the fields of cell biology and biomedicine; [ Medical and scientific research in the field of medical imaging; ] Medical and scientific research in the field of drug discovery and drug development; [ Medical and scientific research services in the field of cancer treatment and diagnosis; ] Medical research; [ Performance of chemical analyses; ] Pharmaceutical drug development services; [ Pharmaceutical product evaluation; ] Pharmaceutical research and development; Pharmaceutical research services; [ Research and development and consultation related thereto in the field of drug discovery and drug development; Research in the field of environmental protection; ] Scientific investigations for medical purposes; Scientific research [ ; Technology consultation and research in the field of biomedicine ]
Owner
- CYPROTEX US, LLC, Beijing, MA, US
- APREDICA LLC, WATERTOWN, MA, US
- Cellumen, Inc., Pittsburgh, PA, US
- Cellumen, Inc., Pittsburgh, PA, US
- Cellumen, Inc., Pittsburgh, PA, US
Prosecution history
- 29 Nov 2023 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 29 Nov 2023 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 29 Nov 2023 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 29 Nov 2023 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Oct 2022 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
- 06 Oct 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Oct 2022 — TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
- 06 Oct 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Oct 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 06 Oct 2022 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
- 30 Sept 2020 — CORRECTION UNDER SECTION 7 - PROCESSED
- 30 Sept 2020 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 17 Jul 2020 — TEAS SECTION 7 REQUEST RECEIVED
- 29 Jun 2020 — TEAS SECTION 7 REQUEST RECEIVED
- 26 May 2020 — TEAS SECTION 7 SURRENDER RECEIVED